-
Hepatitis is the medical term for an inflammation of the liver. It is often caused by an infection with certain viruses. Hepatitis B is mainly spread through blood and other body fluids. The risk of becoming infected with this virus is generally very low in Germany and similar countries. more...
-
Overview
(PantherMedia / Rawpixel) Hepatitis is the medical term for an inflammation of the liver. It is often caused by an infection with certain viruses. more...
-
Overview
The fixed-dose combination of elbasvir / grazoprevir (trade name: Zepatier) has been approved in Germany since July 2016 for the treatment of chronic hepatitis C in adults (inflammation of the liver caused by hepatitis C viruses). more...
-
Overview
The fixed combination of sofosbuvir / velpatasvir / voxilaprevir (trade name: Vosevi) has been approved in Germany since July 2017 for the treatment of chronic hepatitis C in adults. more...
-
Overview
The drug sofosbuvir (trade name: Sovaldi) has been approved since January 2014 for the treatment of hepatitis C infection in adults. Since September 2017, it has also been approved for teenagers over the age of 12. more...
-
Overview
The fixed combination ledipasvir / sofosbuvir (trade name: Harvoni) has been approved in Germany since July 2017 for the treatment of hepatitis C in teenagers aged 12 and over. more...
-
The human body
Many viruses are responsible for diseases. Some are harmless and only trigger a minor cold, while others can cause serious diseases like AIDS. Other diseases caused by viruses include influenza ("the flu"), measles or inflammation of the liver (viral hepatitis). Viruses invade healthy cells and start to multiply from these cells. more...
-
Overview
The fixed combination of sofosbuvir / velpatasvir (trade name: Epclusa) has been approved in Germany since July 2016 for the treatment of chronic hepatitis C in adults. more...
-
Overview
The fixed-dose combination of glecaprevir / pibrentasvir (trade name: Maviret) has been approved in Germany since July 2017 for the treatment of chronic hepatitis C in adults. more...
-
Learn more
Sofosbuvir (Sovaldi) for the treatment of chronic hepatitis C (genotype 2) in adults. In 2014, the Institute for Quality and Efficiency in Health Care (IQWiG, Germany) has examined what advantages and disadvantages the combination of sofosbuvir with peginterferon and/or ribavirin offers in comparison with conventional standard treatments for ... more...
